Pfizer vaccine: Three-dose Covid-19 vaccine produces strong immune response in young children, Pfizer and BioNTech say
The Phase 2/3 trial included 1,678 children who received a third vaccine dose during the period when the Omicron coronavirus variant dominated. Antibody levels tested one month after the third...